Cargando…

Development and Validation of a Patient-Reported Outcome Measure for Fingernail and Toenail Conditions: The NAIL-Q

BACKGROUND: Patient-reported outcome measures (PROMs) are needed to measure outcomes that matter to people with nail conditions, from their perspective. OBJECTIVE: To design a comprehensive new PROM (NAIL-Q) to measure outcomes important in toenail and fingernail conditions. METHODS: A mixed methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Klassen, Anne F, Rae, Charlene, O’Malley, Maureen, Breitkopf, Trisia, Algu, Leah, Mansouri, Jasmine, Brown, Claire R, Wang, Yi, Lipner, Shari R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617399/
https://www.ncbi.nlm.nih.gov/pubmed/37915422
http://dx.doi.org/10.2147/CCID.S429120
_version_ 1785129599022137344
author Klassen, Anne F
Rae, Charlene
O’Malley, Maureen
Breitkopf, Trisia
Algu, Leah
Mansouri, Jasmine
Brown, Claire R
Wang, Yi
Lipner, Shari R
author_facet Klassen, Anne F
Rae, Charlene
O’Malley, Maureen
Breitkopf, Trisia
Algu, Leah
Mansouri, Jasmine
Brown, Claire R
Wang, Yi
Lipner, Shari R
author_sort Klassen, Anne F
collection PubMed
description BACKGROUND: Patient-reported outcome measures (PROMs) are needed to measure outcomes that matter to people with nail conditions, from their perspective. OBJECTIVE: To design a comprehensive new PROM (NAIL-Q) to measure outcomes important in toenail and fingernail conditions. METHODS: A mixed methods iterative approach was used. Phase 1 involved concept elicitation interviews that were audio-recorded, transcribed, and coded line-by-line. Concepts were developed into scales and refined through cognitive debriefing interviews with patients and expert input. Data was then collected from an international sample using a crowdsource platform. Eligible participants were aged ≥18 years with a nail condition for at least 3 months. Rasch Measurement Theory (RMT) analysis was used to examine item and scale performance. Other psychometric tests included test–retest reliability, and convergent and construct validity. RESULTS: Phase 1 interviews involved 23 patients with 10 nail conditions and input from 11 dermatologists. The analysis led to the development of 84 items for field-testing. In Phase 2, 555 participants completed the survey. Toenail conditions (n = 441) were more common than fingernail conditions (n = 186). The RMT analysis reduced the number of items tested to 45 in 7 scales measuring nail appearance, health-related quality of life concerns, and treatment outcomes. All items had ordered thresholds and nonsignificant chi-square p values. Reliability statistics with and without extremes for the Person Separation Index were ≥0.79 and Cronbach’s alpha were ≥0.83, and for intraclass correlation coefficients were ≥0.81. Construct validity was further supported in that most participants agreed that the NAIL-Q was easy to understand, asked relevant and important questions in a respectful way, and that it should be used to inform clinical care. CONCLUSION: The NAIL-Q is a rigorously designed and tested PROM that measures nail appearance, health-related quality of life and treatment outcomes. This PROM can be used in clinical practice to inform patient care and to include the patient perspective in research.
format Online
Article
Text
id pubmed-10617399
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-106173992023-11-01 Development and Validation of a Patient-Reported Outcome Measure for Fingernail and Toenail Conditions: The NAIL-Q Klassen, Anne F Rae, Charlene O’Malley, Maureen Breitkopf, Trisia Algu, Leah Mansouri, Jasmine Brown, Claire R Wang, Yi Lipner, Shari R Clin Cosmet Investig Dermatol Original Research BACKGROUND: Patient-reported outcome measures (PROMs) are needed to measure outcomes that matter to people with nail conditions, from their perspective. OBJECTIVE: To design a comprehensive new PROM (NAIL-Q) to measure outcomes important in toenail and fingernail conditions. METHODS: A mixed methods iterative approach was used. Phase 1 involved concept elicitation interviews that were audio-recorded, transcribed, and coded line-by-line. Concepts were developed into scales and refined through cognitive debriefing interviews with patients and expert input. Data was then collected from an international sample using a crowdsource platform. Eligible participants were aged ≥18 years with a nail condition for at least 3 months. Rasch Measurement Theory (RMT) analysis was used to examine item and scale performance. Other psychometric tests included test–retest reliability, and convergent and construct validity. RESULTS: Phase 1 interviews involved 23 patients with 10 nail conditions and input from 11 dermatologists. The analysis led to the development of 84 items for field-testing. In Phase 2, 555 participants completed the survey. Toenail conditions (n = 441) were more common than fingernail conditions (n = 186). The RMT analysis reduced the number of items tested to 45 in 7 scales measuring nail appearance, health-related quality of life concerns, and treatment outcomes. All items had ordered thresholds and nonsignificant chi-square p values. Reliability statistics with and without extremes for the Person Separation Index were ≥0.79 and Cronbach’s alpha were ≥0.83, and for intraclass correlation coefficients were ≥0.81. Construct validity was further supported in that most participants agreed that the NAIL-Q was easy to understand, asked relevant and important questions in a respectful way, and that it should be used to inform clinical care. CONCLUSION: The NAIL-Q is a rigorously designed and tested PROM that measures nail appearance, health-related quality of life and treatment outcomes. This PROM can be used in clinical practice to inform patient care and to include the patient perspective in research. Dove 2023-10-27 /pmc/articles/PMC10617399/ /pubmed/37915422 http://dx.doi.org/10.2147/CCID.S429120 Text en © 2023 Klassen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Klassen, Anne F
Rae, Charlene
O’Malley, Maureen
Breitkopf, Trisia
Algu, Leah
Mansouri, Jasmine
Brown, Claire R
Wang, Yi
Lipner, Shari R
Development and Validation of a Patient-Reported Outcome Measure for Fingernail and Toenail Conditions: The NAIL-Q
title Development and Validation of a Patient-Reported Outcome Measure for Fingernail and Toenail Conditions: The NAIL-Q
title_full Development and Validation of a Patient-Reported Outcome Measure for Fingernail and Toenail Conditions: The NAIL-Q
title_fullStr Development and Validation of a Patient-Reported Outcome Measure for Fingernail and Toenail Conditions: The NAIL-Q
title_full_unstemmed Development and Validation of a Patient-Reported Outcome Measure for Fingernail and Toenail Conditions: The NAIL-Q
title_short Development and Validation of a Patient-Reported Outcome Measure for Fingernail and Toenail Conditions: The NAIL-Q
title_sort development and validation of a patient-reported outcome measure for fingernail and toenail conditions: the nail-q
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617399/
https://www.ncbi.nlm.nih.gov/pubmed/37915422
http://dx.doi.org/10.2147/CCID.S429120
work_keys_str_mv AT klassenannef developmentandvalidationofapatientreportedoutcomemeasureforfingernailandtoenailconditionsthenailq
AT raecharlene developmentandvalidationofapatientreportedoutcomemeasureforfingernailandtoenailconditionsthenailq
AT omalleymaureen developmentandvalidationofapatientreportedoutcomemeasureforfingernailandtoenailconditionsthenailq
AT breitkopftrisia developmentandvalidationofapatientreportedoutcomemeasureforfingernailandtoenailconditionsthenailq
AT alguleah developmentandvalidationofapatientreportedoutcomemeasureforfingernailandtoenailconditionsthenailq
AT mansourijasmine developmentandvalidationofapatientreportedoutcomemeasureforfingernailandtoenailconditionsthenailq
AT brownclairer developmentandvalidationofapatientreportedoutcomemeasureforfingernailandtoenailconditionsthenailq
AT wangyi developmentandvalidationofapatientreportedoutcomemeasureforfingernailandtoenailconditionsthenailq
AT lipnersharir developmentandvalidationofapatientreportedoutcomemeasureforfingernailandtoenailconditionsthenailq